Valuation: Precipio, Inc.

Market Cap 39.62M 35.94M 33.23M 29.99M 56.54M 3.73B 58.48M 398M 158M 2B 149M 146M 6.33B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 40.62M 36.85M 34.07M 30.75M 57.97M 3.83B 59.95M 408M 162M 2.05B 152M 149M 6.49B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.3%
Yield 2024 *
-
Yield 2025 -
1 day-4.82%
1 week+18.85%
Current month+22.27%
1 month-0.54%
3 months-5.83%
6 months-22.62%
Current year-3.70%
1 week 19
Extreme 18.995
25.34
1 month 17.79
Extreme 17.79
25.34
Current year 17.79
Extreme 17.79
33.63
1 year 17.79
Extreme 17.79
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
48.8
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 2017-05-31
Chief Executive Officer 54 2017-06-27
Director TitleAgeSince
Director/Board Member 54 2017-06-27
Director/Board Member 78 2017-09-25
Director/Board Member 67 2017-11-07
Date Insider Type Main position Quantity % Market Cap. Importance
10/15/26 Free

Director

582 0.0325%
10/15/26 Free

Director

122 0.0068%
7/15/26 Free

Director

520 0.0291%
Change 5-day change 1-year change 3-year change Capi.($)
-4.82%+18.85%+14.49%+184.45% 39.62M
+0.11%+0.79%+21.00%+52.47% 259B
+0.37%+1.20%+5.34%+14.49% 164B
+0.84%-2.03%-19.28%+52.11% 154B
+0.32%+3.72%-56.82%-17.92% 64.27B
+1.28%+4.91%+24.16%+62.87% 61.61B
+0.34%-1.59%+0.18%-11.25% 53.94B
+0.55%-0.46%+18.49%+55.86% 49.04B
-0.29%-0.72%+2.78%+73.84% 48.82B
-0.42%+0.58%+21.31%+77.93% 45.24B
Average -0.17%+2.53%+3.16%+54.49% 90B
Weighted average by Cap. +0.37%+0.57%+3.57%+39.99%

Financials

2024 2025
Net sales 18.53M 16.81M 15.54M 14.03M 26.45M 1.75B 27.35M 186M 73.96M 933M 69.55M 68.06M 2.96B 24.05M 21.82M 20.17M 18.21M 34.32M 2.27B 35.5M 242M 95.98M 1.21B 90.25M 88.33M 3.84B
Net income -4.29M -3.89M -3.6M -3.25M -6.12M -404M -6.33M -43.12M -17.12M -216M -16.1M -15.76M -685M -363K -329K -304K -275K -518K -34.21M -536K -3.65M -1.45M -18.28M -1.36M -1.33M -58M
Net Debt -136K -123K -114K -103K -194K -12.82M -201K -1.37M -543K -6.85M -510K -500K -21.73M 1M 909K 840K 759K 1.43M 94.42M 1.48M 10.07M 4M 50.47M 3.76M 3.68M 160M
Projected Income Statement - Annual - Precipio, Inc.
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
26-11-13 $22.13 -4.82% 14,710
26-11-12 $23.25 -6.25% 22,939
26-11-11 $24.80 +4.86% 28,922
26-11-10 $23.65 +6.53% 21,957
26-11-09 $22.20 +19.23% 47,706
  1. Stock Market
  2. Stocks
  3. PRPO Stock